Investigative Site

Memphis, Tennessee 38157

1 studies enrolling now · 3 studies all time

What they study most

CLE, Cutaneous Lupus Erythematosus (CLE), Heavy Menstrual Bleeding, Menorrhagia, Parkinson Disease, SLE, SLE (Systemic Lupus), Systemic Lupus Erythematosus

Studies at this site

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus — Recruiting now
• A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease — Stopped early
• Efficacy and Safety Study of XP12B in Women With Menorrhagia — Completed